USD 0.01
(4.62%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -9.49 Million USD | -124.9% |
2022 | 38.14 Million USD | 386.31% |
2021 | -13.32 Million USD | -26.05% |
2020 | -10.57 Million USD | 67.08% |
2019 | -32.1 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -1.27 Million USD | 46.59% |
2024 Q1 | -2.38 Million USD | -424.62% |
2023 Q3 | -2.21 Million USD | -53.9% |
2023 FY | -9.49 Million USD | -124.9% |
2023 Q4 | -455 Thousand USD | 79.41% |
2023 Q2 | -1.43 Million USD | 78.11% |
2023 Q1 | -6.55 Million USD | -11.64% |
2022 Q2 | 38.38 Million USD | 222.61% |
2022 Q1 | -31.3 Million USD | -508.61% |
2022 FY | 38.14 Million USD | 386.31% |
2022 Q4 | -5.87 Million USD | -138.02% |
2022 Q3 | 15.45 Million USD | -59.74% |
2021 Q2 | -1.31 Million USD | -18.76% |
2021 FY | -13.32 Million USD | -26.05% |
2021 Q4 | -5.14 Million USD | -15.49% |
2021 Q3 | -4.45 Million USD | -238.19% |
2021 Q1 | -1.1 Million USD | -12.36% |
2020 Q1 | 376.33 Thousand USD | 0.0% |
2020 Q4 | -987 Thousand USD | -1043.58% |
2020 Q3 | -86.3 Thousand USD | 12.79% |
2020 Q2 | -98.96 Thousand USD | -126.3% |
2020 FY | -10.57 Million USD | 67.08% |
2019 Q3 | - USD | 0.0% |
2019 FY | -32.1 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
CannBioRx Life Sciences Corp. | -19.93 Million USD | 52.355% |
BIMI International Medical Inc. | -22.35 Million USD | 57.509% |
China Jo-Jo Drugstores, Inc. | -4.23 Million USD | -124.315% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | -24.41 Million USD | 61.091% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | -24.41 Million USD | 61.091% |
Leafly Holdings, Inc. | -9.49 Million USD | -0.0% |
LifeMD, Inc. | -20.59 Million USD | 53.884% |
LifeMD, Inc. | -20.59 Million USD | 53.884% |
TRxADE HEALTH, Inc. | -17.84 Million USD | 46.771% |
PetMed Express, Inc. | -7.46 Million USD | -27.251% |
Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 99.89% |